List of SBIR/STTR awards granted to Versatope Therapeutics
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Versatope Therapeutics in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001127-01A1 | Phase I | 225,000 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Versatope Therapeutics in March, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136291-01 | Phase I | 225,000 | March 6, 2018 | |||||||
A SBIR Phase I contract was awarded to Versatope Therapeutics in April, 2019 for $224,974.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI141055-01A1 | Phase I | 224,974 | April 5, 2019 | |||||||
A SBIR Phase I contract was awarded to Versatope Therapeutics in August, 2020 for $299,928.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI149901-01A1 | Phase I | 299,928 | August 11, 2020 | |||||||
A SBIR Phase I contract was awarded to Versatope Therapeutics for $450,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 272201800038C-0-0-0 | Phase I | 450,000 |
